This text is translated into Russian by google automatic human level neural machine.
EastRussia is not responsible for any mistakes in the translated text. Sorry for the inconvinience.
Please refer to the text in Russian as a source.
Vaccination against COVID-19 will begin in the fall in the Khabarovsk Territory
In the Khabarovsk Territory, this fall, the delivery of a vaccine against coronavirus is expected. As a result, the flu vaccination campaign will start earlier.
According to the press service of the regional government, the flu vaccination campaign will begin first. Then, in a month, they will begin to vaccinate against coronavirus. The vaccination against COVID-19 itself will take place in two stages: after the first vaccination, 21 days must pass, during which citizens will receive another dose of the vaccine.
According to the deputy chairman of the regional government for social issues Yevgeny Nikonov, the vaccination campaign against influenza should begin at the end of August. Also, refrigerating chambers in polyclinics of the region should be prepared for storing the coronavirus vaccine.
Residents of the region suffering from diabetes and obesity must be the first to receive vaccinations against coronavirus. Before and after vaccination, a weekly survey will be organized for health workers, medical students, police officers, customs officers and airport workers. Business executives will have to arrange medical examinations for their employees on their own.
Influenza vaccination plan has been increased this year. It is planned to cover up to 90% of all residents of the region suffering from chronic diseases. Of the total population, at least 60% of the population must be vaccinated. Particular attention will also be paid to the vaccination of workers in poultry farms, pig farms. For greater coverage, more than 500 mobile teams will be organized.Roszdravnadzor on the eve registered the Russian vaccine from coronavirus. Immunity will persist about two years. Moreover, earlier experts called for the third phase of research to be carried out first, and then register the drug and release it into mass production.